Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG - Schadendorf, Dirk; Ugurel, Selma; Rittgen, Werner; Edler, Lutz; Sucker, Antje (Annals of oncology, 2020)
Elektronische Reproduktion der Druckausgabe